Items Tagged with 'FDA'

American Feed Industry Association criticizes the MAHA Report for unjustly blaming health concerns on modern food and agriculture while ignoring current regulatory systems designed to promote public and animal health.

At the 2025 Food Safety Summit, the much-anticipated Town Hall session on Thursday featured a candid discussion and attendee Q&A with officials from FDA, USDA-FSIS, CDC, and AFDO.

This article examines the health risks of PFAS migration from food packaging, and how food and beverage companies can go about phasing out their use to comply with U.S. Food and Drug Administration (FDA) regulations and state laws.

This article focuses on one of the three branches within the newly created U.S. Food and Drug Administration (FDA) Human Foods Program—the Office of Food Chemical Safety, Dietary Supplements, and Innovation—and its potential impact on food packaging.

FDA’s Final Food Traceability Rule is driving necessary changes to the U.S.’s currently limited traceability system. Industry must continue to build upon the progress it has already made to move the nation toward a harmonized, interoperable traceability system.

Food safety is paramount in the production process, and crucial for protecting consumers from health risks associated with allergens and contaminants.

In the first of this two-part episode of Food Safety Matters, we interviewed professionals from the industry, regulatory, and nonprofit sectors, live from the show floor of the Food Safety Summit, which took place on May 6–9 in Rosemont, Illinois. We discussed food safety culture, food safety regulation for cannabis-infused edibles, traceability, legacy facilities and equipment, and more.

Traceability for Better Supply Chain Visibility and Regulatory Adherence helps you understand how to achieve January 2026 compliance with the U.S. Food and Drug Administration's (FDA's) Food Traceability Final Rule—also known as FSMA 204—regardless of how far along your company is in its traceability journey.

Eliminating redundancies, increasing efficiency, and cultivating a culture of collaboration were the main themes of a January 19 webinar featuring top U.S. Food and Drug Administration (FDA) officials, hosted by Alliance for a Stronger FDA to discuss the agency’s proposed reorganization.

Namandjé N. Bumpus, Ph.D., current Chief Scientist at the U.S. Food and Drug Administration (FDA), will become the next FDA Principal Deputy Commissioner when Janet Woodcock, M.D. retires in early 2024. One of Dr. Bumpus' main priorities is to assist in the proposed reorganization of a unified Human Foods Program, including creating a new model for the Office of Regulatory Affairs (ORA).